Activest Wealth Management
CORT icon

Activest Wealth Management’s Corcept Therapeutics CORT Stock Holding History

Activest Wealth Management’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10.9K Hold
95
– – ﹤0.01% 568
2026
Q2 		$8.26K Buy
+95
New +$5.74K ﹤0.01% 613
2026
Q1 		– Sell
-32
Closed -$1.11K – 1254
2025
Q4 		$1.11K Buy
+32
New +$2.51K ﹤0.01% 937

Other funds holding CORT

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Ingalls & Snyder LLC
Ingalls & Snyder LLC New York $3.91B AUM 60.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Parallel Advisors
Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Activest Wealth Management's CORT Position: Q3 2026 in Review

Activest Wealth Management held its Corcept Therapeutics (CORT) position steady in Q3 2026 at 95 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #568.

Activest Wealth Management first reported a position in CORT in Q4 2025 and has held it in 3 quarters since. 403 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

  • Activest Wealth Management held 95 shares of Corcept Therapeutics worth $10.9K as of Q3 2026.
  • Activest Wealth Management left its Corcept Therapeutics share count unchanged in Q3 2026.
  • Corcept Therapeutics made up ﹤0.01% of Activest Wealth Management's portfolio in Q3 2026, its #568 holding.
  • Activest Wealth Management first reported a position in Corcept Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 403 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.